[PDF][PDF] Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion

RK Avramoglu, W Qiu, K Adeli - Front Biosci, 2003 - article.imrpress.com
RK Avramoglu, W Qiu, K Adeli
Front Biosci, 2003article.imrpress.com
Deregulation of Lipoprotein Metabolism in Insulin Resistant States 2.1. Metabolic
dyslipidemia in insulin resistance 2.2. Insulin regulation of apoB-containing lipoproteins 2.3.
The hepatic insulin signaling pathway and disruption in insulin resistance 2.4. Animal
models of insulin resistance 2.5. The fructose-fed hamster model of insulin resistance 2.6.
Link between changes in hepatic insulin signaling and VLDL secretion in the fructose-fed
hamster model 2.7. Amelioration of insulin resistance reverses hepatic lipoprotein …
Abstract
Deregulation of Lipoprotein Metabolism in Insulin Resistant States 2.1. Metabolic dyslipidemia in insulin resistance 2.2. Insulin regulation of apoB-containing lipoproteins 2.3. The hepatic insulin signaling pathway and disruption in insulin resistance 2.4. Animal models of insulin resistance 2.5. The fructose-fed hamster model of insulin resistance 2.6. Link between changes in hepatic insulin signaling and VLDL secretion in the fructose-fed hamster model 2.7. Amelioration of insulin resistance reverses hepatic lipoprotein overproduction 2.8. Potential link between alterations in ER proteases in insulin resistance and overproduction of hepatic VLDL 2.9. Role of intestinal lipoproteins in metabolic dyslipidemia 3. Conclusions and perspectives 4. Acknowledgements 5. References
article.imrpress.com